Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors

NCT04349267 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

BIOLOGICAL: BMS-986315
BIOLOGICAL: nivolumab
BIOLOGICAL: cetuximab

Sponsor

Bristol-Myers Squibb